最新研究显示,绝经后的乳腺癌女性患者接受含雌激素和孕激素的激素替代治疗(HRT)有可能增加乳腺癌复发的风险。来自于瑞典斯德哥尔摩卡罗林斯卡大学医院的Eva von Schoultz博士及其同事指出,瑞典的两项新的研究评估了绝经后的激素治疗与绝经前的激素治疗对早期乳腺癌患者的影响,在乳腺癌复发风险上 Recent studies show that women with breast cancer after menopause receiving estrogen and progesterone hormone replacement therapy (HRT) may increase the risk of breast cancer recurrence. Eva von Schoultz, PhD, of Karolinska University Hospital, Stockholm, Sweden, and colleagues point out that two new Swedish studies evaluated the effect of postmenopausal hormone therapy and premenopause hormone therapy on patients with early-stage breast cancer. Breast cancer risk of recurrence